Corporate Partner 2025 (2/2):
CHG-MERIDIAN
CHG-MERIDIAN is a global technology financing and lifecycle management company
focusing on IT, industrial, and healthcare technologies. Operating in over 30 countries, the
company supports organizations in managing technology assets efficiently and sustainably
across the entire lifecycle.
​
Case:
Rethinking B2B in the age of AI
​​​
Corporate Partner 2025 (1/2):
HOCH Health Ostschweiz
HOCH Health Ostschweiz is the newly formed hospital group created through the merger of four public hospital networks in the canton of St. Gallen. With over 8,000 employees and a revenue of CHF 1.4 billion, HOCH plays a critical role in ensuring high-quality medical care across Eastern Switzerland. The organization combines the strengths of regional hospitals and the university-level Kantonsspital St. Gallen to build an integrated, forward-looking healthcare system. Its mission is to be the preferred healthcare partner in the region – offering progressive, patient-centered medical services.
The transformation through the fusion “Managementmodell 2024+” opens up new strategic and operational opportunities. From rebranding and employer branding to strategic positioning and synergy tracking, HOCH is reshaping how public hospitals collaborate, grow, and innov
ate under regulatory conditions.
​
Case:
Strategic positioning and competitiveness of regional hospital sites after the merger
Corporate Partner 2024
LGT
LGT is an international private banking and asset management group with a strong focus on
sustainability, long-term value creation, and intergenerational wealth management.
​
Case:
Private Banking and asset management
Corporate Partner 2023:
Roche Diagnostic AG
Roche Diagnostics is a division of the Roche Group. They develop advanced diagnostic solutions that help healthcare professionals make important treatment decisions for their patients. At the same time, they aim to better embed these solutions into global healthcare systems - at lower cost, while ensuring the best outcomes. In more than 100 countries, they offer the broadest in vitro testing portfolio in the industry, as well as tools for consulting, digital diagnostics, disease management, laboratory automation and software systems. The result is integrated solutions for laboratories, healthcare professionals and healthcare systems.
​
Case:
Market strategy for DTC product
Corporate Partner 2022:
Leonteq Securities AG
Leonteq is a Swiss fintech company with a leading marketplace for structured investment solutions. Based on proprietary modern technology, the company offers derivative investment products and services and predominantly covers the capital protection, yield enhancement, and participation product classes. Leonteq acts as both a direct issuer of its own products and as a partner to other financial institutions. Leonteq further enables life insurance companies and banks to produce capital-efficient, unit-linked pension products with guarantees.
​
Case:
Participants developed the solution to a diversity and integration case, a marketing case, and a crypto staking case for Leonteq.
Corporate Partner 2021:
Victorinox
Victorinox was founded in 1891 and manufactures and sells unique high-quality products with practical uses throughout the world. First and foremost is the famous Swiss Army Knife, which has achieved cult status in Switzerland and the rest of the world. In addition to the pocket knife, there are four other product categories: Household and professional knives, watches, luggage and perfume. Victorinox employs 2,100 people and achieved a turnover of around CHF 500 million in 2019.
Case:
Victorinox asked itself how suitable new services and/or business models could be used to attract new target groups and increase direct contact with consumers.